International Society for Neonatal Screening

Tweet this page
<
2020
2021
2022
2023
2024
>
Registration as it was on 25 Aug 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.75 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    International Society for Neonatal Screening   (ISNS)

    EU Transparency Register

    809390039113-90 First registered on 30 Jul 2020

    Goals / Remit

    The vision of the ISNS is to detect neonatal conditions and prevent their adverse outcomes through excellence in neonatal screening.
    The mission of the ISNS is to enhance the quality of neonatal screening and medical services through dissemination of information, guidelines and best practices that benefit all family members and their babies by helping to ensure protection of babies from life-quality threatening conditions, such as phenylketonuria, congenital hypothyroidism, severe combined immunodeficiency, cystic fibrosis, hemoglobinopathies and many others.

    Main EU files targeted

    Harmonisation of Neonatal screening, orphan medicinal product, advanced therapeutic medicinal products, crossborder healthcare directive, rare diseases, equal access to care, research and innovation, patient registries, biobanks, screening laboratory quality guidelines and standardization, treatment of inherited metabolic diseases, next gen sequencing, proteomics, metabolomics, genomics

    Related to: https://ec.europa.eu/health/home_en
    EU Action on Health, Improving health systems (especially European reference networks and digital health and care), Diseases and health threats (especially non-communicable diseases, more specifically, rare diseases),

    Address

    Head Office
    Reigerskamp 273
    Maarssen-Stichtse Vecht 3607HP
    NETHERLANDS
    EU Office
    Reigerskamp 273
    Maarssen-Stichtse Vecht 3607HP
    NETHERLANDS

    Website

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    25%3

    Lobbyists (Full time equivalent)

    0.75

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Please note that all persons are involved as part of their voluntary, pro bono, activities for the International Society for Neonatal screening.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    Please refer to:
    https://www.isns-neoscreening.org/links/

    Additionally:
    Associated with Health First Europe
    ISNS, International patient organisation for Primary Immunodeficiencies (IPOPI) and European Society for Immunodeficiencies (ESID) work the multi-stakeholder Screen4Rare initiative to promote the importance of neonatal screening.
    Screen4Rare is registered at the EU Health Policy Platform https://webgate.ec.europa.eu/hpf/network/home/98

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    10,000€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    0€ - 10,000€

    Other financial info

    As stated in other years, when it comes to European activities the ISNS operates with members that work completely voluntarily, hence a discrepancy between the annual costs for activities (that are low) and the results achieved in a given year. In 2023 we were quite successful, a testimony of which will be published at the EU HPP.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    Harmonisation of neonatal screening in Europe, contributing to PID Forums at the European Parliament, position papers on relevant EU policy initiatives (?), contact with Members of the European Parliament, European Commission officials, to explain and further the vision and mission of ISNS and support IPOPI and ESID. Founding organisation of Screen4Rare which is part of the EU Health Policy platform, Cooperation with MetabERN, RITA and other EU European reference networks

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 28 Sep 2023 Location Brussels
      Subject Meeting of Commissioner Kyriakides with newborn screening associations
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
Download this datacard